| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/19/2007 | CN101088997A Improved process of preparing Raltitrexed |
| 12/19/2007 | CN101088565A Use of miRNA-34a |
| 12/19/2007 | CN101088563A Anticancer composition containing lomustine |
| 12/19/2007 | CN101088562A Anticancer composition containing ranimustine |
| 12/19/2007 | CN101088555A Medicine prepn for inhibiting tumor angiogenesis and cancer cell and enhancing immunity |
| 12/19/2007 | CN101088551A Medicine for treating diseases of liver, gall bladder and pancreas and cancer metastasis |
| 12/19/2007 | CN101088541A Medicine for treating women's tumors and malignant tumors and its prepn proces |
| 12/19/2007 | CN101088536A Specific medicine for treating malignant lymphomas |
| 12/19/2007 | CN101088521A Astragalus medicine prepn and its prepn process |
| 12/19/2007 | CN101088520A Medicine composition for auxiliary treatment of cancer and its prepn and quality control method |
| 12/19/2007 | CN101088516A Chinese medicine prepn for treating leukemia |
| 12/19/2007 | CN101088513A 生命技术及其应用 Life Technologies and Applications |
| 12/19/2007 | CN101088502A Mixture solution containing conjugate of transferrin and quercetin and its use |
| 12/19/2007 | CN101088497A Composition containing lycopane and thioglycoside |
| 12/19/2007 | CN101088496A Microecological bifid bacterium signal molecule prepn and its prepn process |
| 12/19/2007 | CN101088492A Stable supersaturated gemcitabine hydrochloride solution and its prepn process |
| 12/19/2007 | CN101088491A Anticancer composition |
| 12/19/2007 | CN101088352A Glossy ganoderma health tea making process |
| 12/19/2007 | CN100355882C Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody |
| 12/19/2007 | CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives |
| 12/19/2007 | CN100355784C Method for preparing polyethylene glycol-modified alpha-interferon 1b |
| 12/19/2007 | CN100355782C New liver cancer up expressing gene and its encoded protein and application |
| 12/19/2007 | CN100355781C 肽 Peptide |
| 12/19/2007 | CN100355770C Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| 12/19/2007 | CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 12/19/2007 | CN100355744C Separation and extraction of flavone natural product active component for treating prostating disorders and medicinal preparation preparing and use thereof |
| 12/19/2007 | CN100355458C Use of artificial proliferative inhibiting gene-adenovirus expression carrier |
| 12/19/2007 | CN100355454C Nano-magnetic powder antihuman lirer cancer single anti HAb18 target medicine for magnetic heat therapy |
| 12/19/2007 | CN100355423C Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor |
| 12/19/2007 | CN100355422C Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 12/19/2007 | CN100355420C Leucine-enriched nutritional compositions |
| 12/19/2007 | CN100355418C Magnetic nano-balls carried with cisplatin and its prepn. method |
| 12/19/2007 | CN100355417C Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309710 Crystals |
| 12/18/2007 | US7309705 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; anticarcinogenic, antiinflammatory, neurodegenerative agent; arthritis, Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases; with other active compounds |
| 12/18/2007 | US7309692 Inhibition of Grb2 and Crk1 gene products that interact with the bcr-abl product and participate in the transformation of Chronic myeloid leukemia |
| 12/18/2007 | US7309689 Sustained peptide-release formulation |
| 12/18/2007 | US7309688 Topical application of formulation containing non-denatured, soy product in a carrier for inhibiting the progression of a cutaneous tumor |
| 12/18/2007 | US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 12/18/2007 | US7309586 Chimeric coiled coil molecules |
| 12/18/2007 | CA2436799C Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 12/18/2007 | CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer |
| 12/18/2007 | CA2299471C Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 12/18/2007 | CA2249390C Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/18/2007 | CA2219070C Methods of preventing breast cancer |
| 12/18/2007 | CA2209001C Hydrophobic taxane derivatives |
| 12/18/2007 | CA2062047C Fusion proteins for prodrug activation, the preparation and use thereof |
| 12/18/2007 | CA1341566C Immune response to tumors induced by anti-idiotype antibodies |
| 12/13/2007 | WO2007143600A2 Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| 12/13/2007 | WO2007143582A2 Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling |
| 12/13/2007 | WO2007143483A2 Combination of pazopanib and lapatinib for treating cancer |
| 12/13/2007 | WO2007143175A2 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer |
| 12/13/2007 | WO2007143096A2 Compounds for treating cancers |
| 12/13/2007 | WO2007142973A1 Cobalamin compositions and methods for treating or preventing mucositis |
| 12/13/2007 | WO2007142336A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 12/13/2007 | WO2007142277A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 12/13/2007 | WO2007142241A1 Immunocompetent cell having anti-cd38 antibody on its cell surface |
| 12/13/2007 | WO2007142217A1 1-phenylpyridone derivative |
| 12/13/2007 | WO2007142139A1 Method of identifying candidate for remedy of acute myeloid leukemia |
| 12/13/2007 | WO2007142096A1 Inhibitor of inducible nitric oxide synthase, beverage/food, and neutraceutical food |
| 12/13/2007 | WO2007141533A2 Fkbp-l and uses thereof |
| 12/13/2007 | WO2007141473A1 N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl] -l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors |
| 12/13/2007 | WO2007141283A2 Salts and crystalline salt forms of an 2-indolinone derivative |
| 12/13/2007 | WO2007140957A1 Sulfimides as protein kinase inhibitors |
| 12/13/2007 | WO2007140924A1 Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer |
| 12/13/2007 | WO2007140907A1 Use of serine endopeptidases 22 (prss22) as a therapeutic or diagnostic target |
| 12/13/2007 | WO2007140667A1 A ptd-vp3 fusion protein as anti-tumor medecine and preparing process |
| 12/13/2007 | WO2007140662A1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof |
| 12/13/2007 | WO2007140618A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/13/2007 | WO2007140613A1 Fermented milk product and use thereof |
| 12/13/2007 | WO2007140534A1 Vegf-a cross-reactive anti- vegf-b antibodies as antagonists of vegf-a and vegf-b signalling |
| 12/13/2007 | WO2007120827A3 Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders |
| 12/13/2007 | WO2007118660A3 Her-2/neu multi-peptide vaccine |
| 12/13/2007 | WO2007116025A3 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| 12/13/2007 | WO2007111904A3 C-met protein kinase inhibitors for the treatment of proliferative disorders |
| 12/13/2007 | WO2007109251A3 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 12/13/2007 | WO2007064797A3 Inhibitors of c-met and uses thereof |
| 12/13/2007 | WO2007038171A3 Peptide nucleic acid based guanidinium compounds |
| 12/13/2007 | WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
| 12/13/2007 | US20070287826 Production of high molecular mass lectins |
| 12/13/2007 | US20070287754 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
| 12/13/2007 | US20070287745 Laulimalide Analogs and Uses Thereof |
| 12/13/2007 | US20070287737 Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors |
| 12/13/2007 | US20070287725 Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method |
| 12/13/2007 | US20070287724 Substituted Imidazoquinolines, Imidazopyridines, and Imidazonaphthyridines |
| 12/13/2007 | US20070287721 Pyrazolopyridinyl pyridine |
| 12/13/2007 | US20070287718 Methods for the Treatment of Multiple Myeloma Using Roscovitine |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/13/2007 | US20070287706 Certain substituted quinolones, compositions, and uses thereof |
| 12/13/2007 | US20070287703 Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer |
| 12/13/2007 | US20070287680 Combined Active and Passive Targeting of Biologically Active Agents |
| 12/13/2007 | US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof |
| 12/13/2007 | US20070287672 Macromolecular Gsh-Activiated Glyoxylase I Inhibitors |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |